Matches in Wikidata for { <http://www.wikidata.org/entity/Q37222815> ?p ?o ?g. }
- Q37222815 description "article científic" @default.
- Q37222815 description "article scientifique" @default.
- Q37222815 description "articolo scientifico" @default.
- Q37222815 description "artigo científico" @default.
- Q37222815 description "artículu científicu espublizáu en 2013" @default.
- Q37222815 description "bilimsel makale" @default.
- Q37222815 description "scientific article published on 22 May 2013" @default.
- Q37222815 description "vedecký článok" @default.
- Q37222815 description "vetenskaplig artikel" @default.
- Q37222815 description "videnskabelig artikel" @default.
- Q37222815 description "vědecký článek" @default.
- Q37222815 description "wetenschappelijk artikel" @default.
- Q37222815 description "wissenschaftlicher Artikel" @default.
- Q37222815 description "наукова стаття, опублікована в травні 2013" @default.
- Q37222815 description "научни чланак" @default.
- Q37222815 description "مقالة علمية نشرت في 22 مايو 2013" @default.
- Q37222815 name "Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment" @default.
- Q37222815 name "Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment" @default.
- Q37222815 name "Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment" @default.
- Q37222815 type Item @default.
- Q37222815 label "Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment" @default.
- Q37222815 label "Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment" @default.
- Q37222815 label "Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment" @default.
- Q37222815 prefLabel "Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment" @default.
- Q37222815 prefLabel "Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment" @default.
- Q37222815 prefLabel "Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment" @default.
- Q37222815 P1433 Q37222815-70BBFBF8-ACE8-4B0E-81DE-3F8349F8B8CB @default.
- Q37222815 P1476 Q37222815-AC1AE7B3-E66D-49AF-8F14-160ABFAF8295 @default.
- Q37222815 P2093 Q37222815-07100240-3F82-45BB-94CE-ACF8DE49E7D4 @default.
- Q37222815 P2093 Q37222815-3FCAD0FE-09AE-4307-9DFB-423D1109E0FB @default.
- Q37222815 P2093 Q37222815-73BAADE9-F070-4BBB-BC7C-1FF9867968AB @default.
- Q37222815 P2093 Q37222815-9A6E9CD6-B553-4E04-B236-E05C1495B4AA @default.
- Q37222815 P2093 Q37222815-D5D03104-0877-48A5-89AD-9DFF4A4451EF @default.
- Q37222815 P2093 Q37222815-EE194219-0DA1-4D77-9D38-3FD27F10D2FE @default.
- Q37222815 P2093 Q37222815-F6F520ED-FB2E-4B82-A9CD-12046929B45F @default.
- Q37222815 P2860 Q37222815-034F8591-D6C9-438D-A14A-49FBA6CE6955 @default.
- Q37222815 P2860 Q37222815-0A8749C3-3831-4D13-9E14-49255B9249C7 @default.
- Q37222815 P2860 Q37222815-360F873E-EBBF-46C6-AF10-BC964802B43E @default.
- Q37222815 P2860 Q37222815-369BBD77-793F-4E10-8336-B4FB53287EAA @default.
- Q37222815 P2860 Q37222815-384CBB05-B4F7-418B-810E-E2CFF8880345 @default.
- Q37222815 P2860 Q37222815-3FEEF2BC-0488-4ACD-A619-AC96DF850F43 @default.
- Q37222815 P2860 Q37222815-45109916-B4B0-4AA1-8B80-C063CB98F91C @default.
- Q37222815 P2860 Q37222815-53220039-4AB9-4C60-9CEB-8A66AD8248F0 @default.
- Q37222815 P2860 Q37222815-547BF550-EEDA-4705-92D5-FD1A1513546A @default.
- Q37222815 P2860 Q37222815-58429D51-EC08-40F7-B0FE-75924C32290E @default.
- Q37222815 P2860 Q37222815-5A4E2BEA-EDA3-4A0D-8625-897AFB2464DD @default.
- Q37222815 P2860 Q37222815-5F33C797-2BE5-403C-A5EA-C6D77927BD6B @default.
- Q37222815 P2860 Q37222815-61253E70-E6F3-426A-AD20-BE787F77AE30 @default.
- Q37222815 P2860 Q37222815-6127D8F6-DDC7-4D0E-A89E-CC91C761CC63 @default.
- Q37222815 P2860 Q37222815-636C72A8-E6D1-41D3-83D7-FE7D62ECF112 @default.
- Q37222815 P2860 Q37222815-6B1CFF51-19BA-42E0-B5DB-63E165E31C88 @default.
- Q37222815 P2860 Q37222815-77758AB0-F325-4ACF-B0FF-3CD1E7AC6840 @default.
- Q37222815 P2860 Q37222815-7EE4EDDA-45E8-4D4D-8066-E05855E3C503 @default.
- Q37222815 P2860 Q37222815-8015D6AF-2538-4558-8208-43066AA78F36 @default.
- Q37222815 P2860 Q37222815-873DC317-0E00-4E82-B2A5-3E8260E25552 @default.
- Q37222815 P2860 Q37222815-8F414CBA-95F9-4B43-B349-BBA6E0E1494E @default.
- Q37222815 P2860 Q37222815-A10EF8E0-CC5D-42DE-BC32-782A46BA7F12 @default.
- Q37222815 P2860 Q37222815-A99BD7B6-3DB4-4C0A-9A44-A25C2F37A82A @default.
- Q37222815 P2860 Q37222815-B4AB695B-1CB4-42A5-93A0-8CEB4AF182A2 @default.
- Q37222815 P2860 Q37222815-E5EFFDB7-562B-47C6-9D0D-395892FC4678 @default.
- Q37222815 P2860 Q37222815-ED6F6511-C506-47ED-9E0D-9B2E1BDC62B8 @default.
- Q37222815 P2860 Q37222815-F5F17DA4-7DA1-494E-9DAC-988BD382608B @default.
- Q37222815 P2860 Q37222815-F68352C5-C039-438B-88DC-5A493B0968DF @default.
- Q37222815 P2860 Q37222815-FB7C7E7C-E50D-455D-AFC3-231CA82FDE15 @default.
- Q37222815 P304 Q37222815-963EDB3E-3489-497F-86E4-15201B099247 @default.
- Q37222815 P31 Q37222815-1CA2B31F-1A78-486D-8238-3892A824172E @default.
- Q37222815 P356 Q37222815-59D6DA50-E976-4127-A338-B617F95E03B7 @default.
- Q37222815 P433 Q37222815-6FC3F76B-0C7E-43C4-904B-E4DDB1813999 @default.
- Q37222815 P478 Q37222815-58D3181F-D6E9-4E7D-B5DC-6F5C9D1ADB81 @default.
- Q37222815 P577 Q37222815-11F5EC60-3F6C-4C01-9866-DB1676D27226 @default.
- Q37222815 P698 Q37222815-D7947ACF-2C26-49D5-8031-8588B2A41537 @default.
- Q37222815 P921 Q37222815-05a6f252-b7aa-42cf-ae19-11ea1623c4d9 @default.
- Q37222815 P921 Q37222815-CD134EFC-BA11-4EA4-BB2D-3C02BDD59CA6 @default.
- Q37222815 P932 Q37222815-2FC0221B-0E33-4A68-8140-D503626B3898 @default.
- Q37222815 P356 JIR.2013.0001 @default.
- Q37222815 P698 23697556 @default.
- Q37222815 P1433 Q15754749 @default.
- Q37222815 P1476 "Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment" @default.
- Q37222815 P2093 "Cong Li" @default.
- Q37222815 P2093 "Desalegn Admassu Ayana" @default.
- Q37222815 P2093 "Huifan Ji" @default.
- Q37222815 P2093 "Maosheng Liu" @default.
- Q37222815 P2093 "Pin Lv" @default.
- Q37222815 P2093 "Yanfang Jiang" @default.
- Q37222815 P2093 "Yanjun Cai" @default.
- Q37222815 P2860 Q24536244 @default.
- Q37222815 P2860 Q27008912 @default.
- Q37222815 P2860 Q28295265 @default.
- Q37222815 P2860 Q28679180 @default.
- Q37222815 P2860 Q29618957 @default.
- Q37222815 P2860 Q30155438 @default.
- Q37222815 P2860 Q33526947 @default.
- Q37222815 P2860 Q34168692 @default.
- Q37222815 P2860 Q34362568 @default.
- Q37222815 P2860 Q35040078 @default.
- Q37222815 P2860 Q35101348 @default.
- Q37222815 P2860 Q35136724 @default.
- Q37222815 P2860 Q35289509 @default.
- Q37222815 P2860 Q35718665 @default.
- Q37222815 P2860 Q36004251 @default.